Blogs

Components for vial containment systems are offered in an array of options; for stoppers they are elastomer type, configuration, size, and surface treatment (coating or laminate). Stopper selection is based on: (a) compatibility with the vial selected and (b) system ability to protect the drug product through shelf life.

As a part of West's ongoing investment in the Asia Pacific region, the company recently relocated to a new office facility in Seoul, South Korea and expanded its warehouse capacity. This strategically positions West in key markets with enhanced scalability to support the future growth needs of its customers.Cindy Reiss-Clark, Chief Commercial Officer and Nilesh Shah, Vice President and General Manager, Emerging Markets joined the Korea team in hosting a group of valued customers at a ribbon cutting event to mark the occasion.

The landscape of healthcare is continuously evolving, driven by innovations in biologics that offer diverse treatment options and better patient outcomes. With an ever-expanding pipeline and increasing competition, it's important to strategize the lifecycle of your drug product effectively, especially concerning its packaging.

In 2004, a small group of West team members started a group dedicated to philanthropic work and giving back at West, naming the team West without Borders.* 20 years later, that group has grown to over 70 team members across the globe, leading the charge to give back year after year. As West’s charity arm that’s led exclusively by team members, West without Borders has made a worldwide impact with a passion for community support that is the embodiment of West’s culture and employee experience.

A container closure system (CCS) is comprised of packaging components, such as a vial and stopper, that together, contain and protect the drug product. There are many different packaging formats that you can select for your CCS, so it is important to have a thorough understanding of the various components included in the CCS, their required function, storage temperature and conditions, and the overall administration of the drug product.

A Primer on the Roadmap for Developing an Injectable Combination Product